Histogen: Of This Current Report On Form 8k Shall Not Be Deemed To Be Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section, And Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Filed Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Except As Shall Expressly Be Set Forth By Specific Reference In Such Filing, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Histogen Inc (formerly Conatus Pharmaceuticals Inc)
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***